The mechanism of the increase in coronary heart disease risk associated with smoking is unclear, but may partly be due to smoking-related changes in intermediate risk factors such as lipid levels, fibrinogen and blood pressure. We therefore examined the distribution of these variables among smokers and non-smokers in the Mü nster Heart Study.
Introduction
Cigarette smoking has been long recognised as a major risk factor for the development of coronary heart disease [1, 2] , but the mechanisms underlying this association are unclear. Consumption of cigarettes exposes the smoker to a range of harmful substances including nicotine, carbon monoxide and other gaseous products, and free radicals, all of which have a potential impact on the processes of atherogenesis and thrombosis [3] . In addition, the habit of smoking may influence other aspects of lifestyle such as physical activity or diet in a manner which will contribute further to the risk of coronary heart disease [4] [5] [6] . However, cigarette smoking alone is not sufficient to generate a high level of coronary disease in a population, since south-east Asian countries such as Japan have low rates of coronary heart disease despite the large number of men who smoke in such countries. In Western countries, by contrast, cigarette smoking is associated with a marked increase in risk of coronary heart disease and coronary death, even when intermediate risk markers for coronary heart disease such as the levels of lipids and fibrinogen are taken into account. In addition to its direct association with increased risk of coronary heart disease, however, smoking cigarettes also produces deleterious changes in these intermediate risk markers, thus contributing indirectly to coronary heart disease. This subject has received increased attention in recent years [3] . It has also been suggested that the pattern of high triglycerides and low HDL (high density lipoprotein) cholesterol seen in smokers may result from smoking-induced insulin resistance [7, 8] . The Mü nster Heart Study (previously known as the Prospective Cardiovascular Mü nster study, or PROCAM), which was started in 1978, is one of the largest prospective epidemiological study of risk factors for coronary heart disease and atherosclerosis in Europe and has gathered data on persons at work in the north-western region of Germany. We here present our analysis of the effects of smoking on coronary heart disease risk markers and coronary heart disease incidence in this population.
Subjects and methods
The Mü nster Heart Study is a prospective epidemiological study of people at work in 52 companies and local government authorities in the north-western German regions of Mü nster and the Ruhr valley. The first phase of recruitment, which was started in 1978 was completed at the end of 1985, after 19 689 subjects had agreed to participate. In the second and third rounds of recruitment, from 1986-1991, and 1992-1995, an additional 3918 and 7301 persons were included. Thus overall, the study comprised 30 908 individuals. The aim of the study was to determine the prevalence of risk factors for coronary heart disease in a German population and to analyse the relationship between risk factors and the subsequent incidence of myocardial infarction or death from coronary heart disease or other causes.
Participants were examined once at entry for cardiovascular risk factors and kept under observation to record mortality, as well as cardiovascular events including myocardial infarction and stroke. The examination at study entry included: a case history using standardized questionnaires; measurement of blood pressure and anthropometric data; a resting electrocardiogram; the collection of a blood sample after a 12 h fast for the determination of more than 20 laboratory parameters. The examination was carried out during paid working hours. Participation was voluntary and between 40 and 80% (on average 60%) of available employees took part. Apart from the loss of working time, participation was free of charge to both the volunteers and their employers. All findings were reported to the participants' general practitioners, and the volunteers were informed whether the results of the examination were normal or whether a check-up by the general practitioner might be necessary. The investigators neither arranged for nor carried out any intervention. Subjects with a history of myocardial infarction or stroke at entry to the study were excluded from the present analysis.
Systolic and diastolic readings were taken on the left arm with the subject seated and the arm at heart level. One measurement was taken at the start of the interview by the examining physician and one at the end of the interview. The second measurement was recorded. The cigarette smoking history was obtained during the examination and used to divide participants into the following six classes: class 1, never smoked any form of tobacco; class 2, ex-smokers of pipe and/or cigars (in each case, 'ex' implies d1 year of abstinence), never smoked cigarettes; class 3, current smokers of pipe and/or cigars, never smoked cigarettes; class 4, current smoker of pipe and/or cigars, ex-cigarette smoker; class 5, current non-smoker, ex-cigarette smoker; class 6, current cigarette smoker. In the present report, only participants in smoking class 6 (current cigarette smokers) were considered to be current smokers. All others, including those who smoked a pipe and/or cigars (groups 1-3) and ex-cigarette smokers (groups 4 and 5) were classified as non-smokers, except for the analysis shown in Table 2 , in which ex-smokers (groups 4 and 5) were considered separately. This classification was chosen to avoid difficulties in assessing tobacco exposure in persons who smoke only a pipe and/or cigars and to avoid generating subgroups too small to analyse. The cigarette consumption of persons who gave up smoking within 12 months prior to the examination was considered to be equal to the amount they were smoking before they gave up.
A 'major coronary event' in this study was defined as the presence of a definite fatal or non-fatal myocardial infarction on the basis of ECG and/or cardiac enzyme changes, or of sudden cardiac death as described. Sudden cardiac death was diagnosed if a participant who had been previously well was observed to have died within 1 h of the onset of symptoms, and if the death could not reasonably be attributed to violence, trauma, or some other potentially lethal disorder other than coronary heart disease. Fatal myocardial infarction was diagnosed if acute myocardial infarction was detected as the cause of death on autopsy or if the death certificate or hospital record described this as the cause of death following pre-terminal hospitalization with definite or suspected myocardial infarction. Definite non-fatal myocardial infarction was diagnosed when one or more of the following occurred: diagnostic ECG at the time of the event; ischaemic cardiac pain (severe substernal pain having a deep or visceral quality and lasting for at least 30 min) plus diagnostic rise in cardiac enzymes; ischaemic cardiac pain plus equivocal enzyme changes plus equivocal electrocardiogram; electrocardiogram diagnostic for myocardial infarction with previous electrocardiogram showing no signs of myocardial infarction. An electrocardiogram was considered diagnostic if there was an unequivocal Q or QS wave pattern (Minnesota code 1-1 [9] ) or if, in the absence of ventricular conduction defects, there was a Q or QS wave pattern (Minnesota codes 1-2-1 to 1-2-7) plus any T wave item (Minnesota codes 5-1 to 5-3). An electrocardiogram was considered equivocal if there was a Q or QS pattern (Minnesota codes 1-2-1 to 1-2-7), ST-junction depression (Minnesota codes 4-1 to 4-3), a T wave item (Minnesota codes 5-1 and 5-2), or left bundle branch block (Minnesota code 7-1). Cardiac enzymes measured at the time of the event were considered diagnostic if serum creatine kinase, glutamate oxaloacetate transaminase and/or lactate dehydrogenase were at least twice the upper limit of the normal range in the laboratory performing the measurements, but not greater than 15 times this value. Enzymes were considered equivocal if at least one was elevated but without reaching the 
Subgroup analysis
In the cohort of men aged 40 to 65 years recruited before the end of 1985, a sufficient number of major coronary events occurred with a follow-up period of 8 years to allow statistically valid longitudinal analysis. Among women and in younger men, numbers were insufficient to permit such analysis.
A participant was considered diabetic if a diagnosis of diabetes mellitus was known or if the glucose level in a fasting specimen of blood was above 6·7 mmol . . Total cholesterol, triglycerides and HDL cholesterol were measured using enzymatic assays and (for HDL cholesterol) a precipitation method from Boehringer Mannheim, Germany, on a Hitachi 737 autoanalyzer. LDL cholesterol was calculated by the Friedewald formula [10] providing the level of triglycerides was below 4·5 mmol . l 1 . For this reason, LDL cholesterol levels are not available for the entire study population. In all persons recruited between mid-1981 and the end of 1985, clottable fibrinogen was determined according to Clauss [11] using thrombin and control plasma from Behringwerke, Marburg, Germany and a plasma pool.
Statistical analysis
An explorative analysis of the data was first performed using the Statistical Package for the Social Sciences (SPSS-X) [12] and the Statistical Analysis System (SAS) [13] . Comparisons between groups were conducted with the Mann-Whitney U test for continuous variables and the chi-square test for discrete variables. All variables were adjusted for age by dividing the participants into 10-year age groups and then weighting the results of each group of smokers and non-smokers according to the fraction of members of the total cohort within that particular age group. To test whether differences between smokers and non-smokers varied between the sexes, a multivariate statistical analysis was performed using, as the independent variables, age, sex, smoking and sex:smoking interaction term; the dependent variables consisted of the coronary risk factors. In the longitudinal analysis, the simultaneous contributions of several factors to the risk of major coronary events were analysed using a multiple logistic model. In the analyses, the criterion for inclusion of a variable in the model was that its initial probability and its partial probability in the presence of other variables should not exceed 0·05.
Maximum likelihood statistics were used to select variables. As a last step, interactions between the variables in the model were tested.
Follow-up
Questionnaires were sent to the participants every 2 years to determine the occurrence of myocardial infarction, stroke or death. At the initial examination, participants were told that they would obtain a questionnaire every 2 years. The response rate to these questionnaires was 96% after an average of two reminders per person by mail and telephone. The death certificates of all deceased study participants were reviewed. In each case in which evidence of morbidity or mortality was entered in the questionnaire, hospital records and records of the attending physician were reviewed and, in the case of deceased study participants, an eye-witness account of death was sought. This data was then reviewed by a Critical Event Committee in order to verify the diagnosis or the cause of death. The members of the critical event committee were: Prof. K. Kochsiek, Wü rzburg, Germany; Prof. B. E. Strauer, Dü sseldorf, Germany; Prof. U. Gleichmann, Bad Oeynhausen, Germany; Prof. E. Kö hler, Bad Salzuflen, Germany. The initial examination was repeated after 6 to 7 years.
Results

Recruitment and demographics
Of the 30 908 individuals enrolled between December 1978 and December 1995, 33% were women (age 37·0 2·6 (mean SD) years, range 20-60 years) and 67% were men (age 41·7 2·7 years, range 20-60 years). Thirty-four percent of participants smoked (32% of the women, 36% of the men). For men, the distribution of smokers, ex-smokers and non-smokers among the age groups was as follows: 20-29 years: smokers 45·6%, ex-smokers 13·8%, non-smokers 40·6%; 30-39 years: 41·9%, 23·6%, 34·5%; 40-49 years: 33·0%, 32·0%, 35·0%; 50-60 years: 26·8%, 40·2%, 33·0%. The distribution among women was as follows: 20-29 years: 38·1%, 12·4%, 49·5%; 30-39 years: 37·9%, 17·4%, 54·7%; 40-49 years: 29·2%, 12·9%, 57·9%; and 50-60 years: 19·6%, 12·6%, 67·8%. Thus, while older women were more commonly non-smokers, older men were more often smokers. Based on self-reporting, 44% of the men who had ever smoked had given up smoking at the time of entry into the study. Of male smokers, 27% smoked 1 to 14 cigarettes per day, 51% smoked between 15 and 24 cigarettes per day and 22% smoked 25 cigarettes or more per day. At the time of entry into the study, only 27% of the women who had ever smoked had given up smoking. However, reported cigarette consumption among women was markedly less then that of men: 42% of women smoked between 1 and 14 cigarettes per day, 45% between 15 and 24 and only 13% of current women smokers smoked 25 cigarettes or more per day. The mean daily cigarette consumption was 18·9 9·0 per day in men and 15·8 7·8 per day in women.
Effect of smoking on incidence of coronary heart disease
During 8 years of follow-up, 13 events occurred among the 3317 female smokers and 12 among the 6895 female non-smokers in our study, yielding an age-adjusted odds-ratio of 2·13 (95% confidence interval 0·97-4·66).
In this time, only 14 events occurred in men aged less than 40 years, nine among 4584 smokers and five among 5654 non-smokers, yielding an odds-ratio of 2·49 (95% confidence interval 0·85-7·27). Because of the small numbers, neither of these differences was statistically significant. Thus the latest (8 year) evaluation of the Mü nster Heart Study only allows reliable estimation of coronary risk among the subgroup of men aged 40 to 65 years. In this group, 9·1% of smokers (132/1444) suffered a major coronary event, whereas only 3·9% of nonsmokers (126/3195) did so, indicating a 2·3-fold increase in overall risk of coronary heart disease (95% confidence interval: 1·83-2·94). Moreover, smokers in this group were at substantially increased risk of major coronary events at all levels of the major risk factors total cholesterol, LDL cholesterol, HDL cholesterol and fibrinogen ( Fig. 1) . Thus, the risk of suffering a major coronary event was some two to three times greater among smokers than non-smokers at all total and LDL cholesterol levels (Fig 1(a) and 1(b) ). Similarly, smokers had between two and three times the non-smokers' risk of a major coronary event at all levels of HDL cholesterol ( Fig. 1(c) ). When coronary risk was stratified according to tertiles of LDL cholesterol/HDL cholesterol ratio ( Fig. 1(d) ), smokers exhibited approximately twice the risk of non-smokers. When risk was stratified according to tertiles of fibrinogen, smoking was again associated with an approximate doubling of risk in men with high and low fibrinogen levels (Fig 1(e) ). In a multivariate logistic function analysis [14] , smoking remained an independent predictor of coronary heart disease (1·8-fold increase in coronary heart disease risk, 95% confidence interval 1·19-2·63), even after allowing for age, sex, HDL cholesterol, LDL cholesterol, triglycerides, systolic blood pressure, fibrinogen, angina, and presence of a history of diabetes mellitus or of a family history of ischaemic heart disease.
Smoking and risk markers of coronary heart disease
The mean age-adjusted levels of a variety of risk markers of coronary heart disease in smokers and non-smokers are shown in Table 1 . Among both men and women, smoking was associated with a slight but statistically significant (P<0·001) increase in mean levels of total cholesterol, LDL cholesterol, triglycerides and fibrinogen. The level of HDL cholesterol was significantly reduced in smokers of both sexes, as were the body mass index and both the systolic and diastolic blood pressures. The mean LDL cholesterol/HDL cholesterol ratio was, therefore, significantly increased in smokers of both sexes.
In order to investigate whether a dose-response relationship existed between differences in these variables and smoking behaviour, consumption of cigarettes was classified into five groups (from the least to the greatest: 'non-smoker' (persons in smoking group 6 as defined in the methods); 'ex-smoker' (persons in smoking groups 4 and 5), '1 to 14 cigarettes per day', 115 to 24 cigarettes per day', '25 or more cigarettes per day'). A statistically significant graded relationship was seen in both men and women between smoking and the level of total cholesterol, LDL cholesterol, triglycerides, HDL cholesterol, the LDL cholesterol/HDL cholesterol and total cholesterol/HDL cholesterol ratios, and the fibrinogen level (Table 2) .
Smoking-related differences in risk markers for coronary heart disease according to sex Table 3 summarizes the smoking-related mean percentage differences in risk markers for coronary heart disease in men and women. Differences in HDL cholesterol and triglycerides are similar for both men and women, while other variables show marked differences between the sexes. The mean increase in total cholesterol in women was twice that of men and that of LDL cholesterol was almost four times as great, leading to a 1·5-fold greater increase in the LDL cholesterol/HDL cholesterol ratio in female than in male smokers. By contrast, the mean fibrinogen level increased by more than three times as much in male as in female smokers, while the mean fall in body mass index in male smokers was more than three times as great as that in female smokers.
Differences in the proportions of individuals with at-risk parameter levels
Despite the fact that the mean increases or decreases in risk parameters tended to be small, they still led to a marked increase in the number of individuals with markedly abnormal parameters. Thus the percentage of men with LDL cholesterol levels above the cut-off point of 5·0 mmol . l 1 was 24% greater among smokers than among non-smokers, while the prevalence of an LDL cholesterol level above 5·0 mmol . l 1 was 60% greater among female smokers than among female non-smokers (Table 4) . Similarly, the prevalence of triglycerides above 2·3 mmol . l 1 was increased by 37% and 59%, that of low HDL<0·9 mmol . l 1 in men and <1·2 mmol . l 1 in women by 64% and 54%, and that of
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an LDL cholesterol/HDL cholesterol ratio above 5 by 80% and 135% in male and female smokers, respectively. The prevalence of hypertension (systolic blood pressure>160 mmHg and/or diastolic blood pressure >95 mmHg) was reduced by 19% and 17·8% in male and female smokers, respectively. 
Discussion
The Mü nster Heart Study is a large prospective study of people at work. Laboratory variables, physical examination and a standardized history were recorded once at recruitment and the participants were then followed at 2-yearly intervals by questionnaire and by inspection of physician and hospital records, if necessary. Table 1 Age-adjusted mean levels ( SD) of coronary heart disease risk markers among participants in the Münster Heart Study. For the purposes of this analysis, ex-smokers were considered as non-smokers, this explains the slight difference between the values for non-smokers shown here and in Table 2 . Because of the large numbers of persons in each group, the differences between smokers and non-smokers in all of these risk markers were significant at the P<0·001 level 
*for fibrinogen, non-smokers n=2948 (males), 1745 (women); ex-smokers n=2641, 350; 1-14 cigs/day n=740, 420; 15-24 cigs/day n=1261, 436; d25 cigs/day n=645, 153. †for LDL, non-smokers n=7128 (males), 5299 (women); ex-smokers n=5661, 1192; 1-14 cigs/day n=1895, 1295; 15-24 cigs/day n=3574, 1396; d25 cigs/day n=1547, 416. TC=total cholesterol, LDL=LDL cholesterol, TG=triglycerides, HDL=HDL cholesterol, (mean SD).
In our population, smoking was associated with significant adverse differences in many intermediate risk factors for atherosclerosis and coronary heart disease, including fibrinogen and lipid levels. Possible confounders of the effect of smoking on these variables are age and sex. However, all date were corrected for age, and results in men and women are displayed separately to eliminate the confounding effect of sex. Body mass index, alcohol consumption and diet, factors which affect plasma lipoproteins, usually differ between smokers and non-smokers and are therefore further possible confounders [4, 6, [15] [16] [17] [18] [19] [20] . In the present and previous studies [21, 22] , smokers had a lower body mass index than non-smokers, a characteristic which is usually associated with an improved, and not a worsened, profile of coronary risk factors [23] [24] [25] [26] [27] [28] . Moreover, the effect of smoking on cholesterol, triglycerides and fibrinogen was dose-dependent in nature (Table 2) , a feature which is compatible with confounding only if the intensity of remaining possible confounders such as alcohol intake or diet varied in step with changes in tobacco consumption.
As has been observed in several other studies [1, 2, [29] [30] [31] [32] , smoking in our population was associated with a striking increase in the risk of major coronary events. This also cannot be explained by confounding, since the incidence of coronary events. This also cannot be explained by confounding, since the incidence of coronary heart disease was greater in smokers than in non-smokers at all levels of intermediate risk factors including plasma lipoproteins (Fig. 1) . Also, in multivariate logistic function analysis, smoking remained an independent predictor of coronary heart disease even after all other major risk factors had been [43] . taken into account [32] . Other large prospective studies have also shown smoking to be an independent predictor of coronary heart disease. In the Framingham study, smoking remained an independent risk marker after age, total cholesterol, systolic blood pressure and normalized body weight were taken into account using Cox and Weibull regression models [33] . Similarly, in the Gö ttingen Risk, Incidence and Prevalence study, smoking was an independent predictor of coronary heart disease after accounting for LDL cholesterol, HDL cholesterol, family history of myocardial infarction, lipoprotein (a), age, systolic blood pressure and plasma glucose by means of multivariate logistic regression [34] . It has been known for some time that smoking affects circulating lipoproteins. Earlier studies such as the Lipid Research Clinics Program Prevalence Study [35] and the Framingham Study [36] tended to concentrate on the smoking-associated lowering of HDL cholesterol. Smoking, however, is associated with changes in all lipid fractions and in a variety of other risk variables. In a meta-analysis of 54 published studies, Craig et al. [37] concluded that smoking is associated with a 3·0% increase in serum cholesterol, a 9·1% increase in triglycerides, a 1·7% increase in LDL cholesterol, and a 5·7% decrease in HDL cholesterol. In our population, smoking was associated with smaller increases in total cholesterol of 1% in men and 2% in women, but with larger increases in triglyceride of 15% in men and 12% in women and greater decreases in HDL cholesterol of about 7% in both men and women. These differences may reflect variations between the populations studied. Our population differs from that of many other studies in consisting of persons at work, who are more healthy and active than the population as a whole. This is reflected in the fact that overall mortality in PROCAM participants is only 69% the age-and sex-matched national German average [32] . The absolute or percentage differences in mean lipid levels in smokers in the present study were not large. Nevertheless, they represent a shift of the entire distribution curve to the right (in the case of cholesterol or triglycerides) or to the left (in the case of HDL) and lead to large differences in the number of individuals with extreme values. Thus, among female smokers the proportion with an LDL cholesterol d5·0 mmol . l 1 is 58% greater than that among female non-smokers. The differences in the proportions with extreme levels of total cholesterol, HDL cholesterol and triglycerides are equally striking.
Recent reports have suggested a link between smoking and insulin resistance [38] . In a study by Facchini et al. [7] , smokers were found to have a greater insulin response to a glucose load than non-smokers and to have higher steady-state plasma glucose concentrations in response to a continuous infusion of glucose, insulin and somatostatin. A further report by Eliasson et al. indicated that the degree of insulin resistance in smokers correlates with the number of cigarettes smoked [8] . These authors also reported insulin resistance and hyperinsulinaemia in long-term users of nicotine chewing gum [39] . However, not all authors have been able to confirm the findings of insulin resistance [40] or increased insulin concentrations [41] in smokers. Insulin resistance is one component of the so-called 'metabolic syndrome' [42] . Whereas, in our population, smokers as a group showed some features of this syndrome such as high triglycerides and low HDL, other features such as obesity and hypertension were absent. In fact, smokers had significantly lower systolic and diastolic blood pressures and lower body mass indices than non-smokers. The levels of blood glucose and uric acid did not differ significantly between smokers and non-smokers. These findings do not, of course, rule out the presence of smoking-induced insulin resistance in some members of our population, since we did not measure insulin levels or perform formal testing of glucose tolerance or sensitivity to insulin. In a report by Freeman et al. on 87 male and 110 female smokers [43] it was claimed that the main impact of smoking in women is on triglycerides, with secondary effects on LDL and HDL, whereas in men smoking has little effect on triglycerides and affects HDL more directly. In our population, by contrast, the mean percentage increase in both native and log-transformed triglyceride levels was greater in men than in women (Table 3) . Moreover, correction for age, body mass index and alcohol intake (in analogy to the study by Freeman et al.) did not abolish but rather increased the effect of smoking on triglyceride levels in men (Table 3) .
In our population, differences existed between the sexes in the dose-response relationships between LDL cholesterol, HDL cholesterol and fibrinogen levels and exposure to cigarettes (Table 2 ). In men, the LDL cholesterol and fibrinogen levels of non-smokers (i.e. never smokers) were less than those of ex-smokers (as one might expect); in women, however, non-smokers had higher LDL and fibrinogen levels than ex-smokers. In addition, while the mean HDL cholesterol level in female non-smokers was lower than that of female ex-smokers, male non-smokers showed higher HDL levels than male ex-smokers. The anomalous relationship of HDL cholesterol, LDL cholesterol and fibrinogen levels to the extent of cigarette exposure in women cannot be explained on the basis of age, since all data in the present study were age-corrected. The explanation may lie, at least in part, in the different social contexts of smoking in women and men in Germany. Whereas, in the past, educated German women tended not to smoke, the habit is now most common among such women. Thus the social composition of the female non-smoking, ex-smoking and smoking groups may have changed over the time of our observations. No such social classrelated changes in smoking behaviour are believed to have occurred among German men, so that the make-up of the non-smoking, ex-smoking and smoking groups is likely to have remained constant. It is therefore possible that the female non-smokers in our population represent an unusual sub-group different from the overall female population in other ways in addition to smoking behaviour. This may explain their atypical appearance between the ex-smokers and light smokers in the Smoking, lipoproteins and coronary heart disease in the Münster Heart Study 1639 measurements of the graded effects of smoking on HDL cholesterol, LDL cholesterol and fibrinogen.
In summary, our study showed that in persons at work in a highly industrialized country, smoking cigarettes was associated with statistically significant adverse changes in intermediate risk markers, which, though small in the mean, resulted in large increases in the number of individuals with at-risk levels of these markers. In addition, smoking was associated with a more than two-fold increase in coronary heart disease event risk in men aged 40 to 65 years, an increase which was present at all levels of the risk factors total, LDL and HDL cholesterol, triglyceride and blood pressure.
